STOCK TITAN

USANA HEALTH SCIENCES INC (USNA) SEC Filings, Jul 1-28, 2025

USNA NYSE

Welcome to our dedicated page for USANA HEALTH SCIENCES SEC filings (Ticker: USNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

USANA Health Sciences, Inc. filings document financial results, management commentary and Regulation FD disclosures for a health and wellness products company. Form 8-K reports cover quarterly and annual results, preliminary sales information, guidance, exhibits and conference-call materials tied to the company’s operating updates.

Proxy and governance filings address director elections, board matters, executive compensation, equity awards and pay-versus-performance disclosure. Other material-event reports document leadership changes, transition agreements and compensatory arrangements, providing formal records of governance and management structure for USANA Health Sciences.

Rhea-AI Summary

On 07/24/2025, USANA Health Sciences (USNA) director Frederic J. Winssinger filed a Form 4 showing the conversion of 1,058 restricted stock units (transaction code “M”) into the same number of common shares. The move increased his directly held common stock to 6,929 shares, up from 5,871, an 18% rise. No shares were sold.

Winssinger still owns 3,172 RSUs that vest in four equal 25 % tranches on 24 Jul 2025, 23 Oct 2025, 22 Jan 2026 and 23 Apr 2026. The filing lists a zero exercise price, typical for RSU settlement, and contains no additional corporate events or financial data. While modest, an insider increasing holdings is generally viewed as a constructive signal rather than a liquidity event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

USANA Health Sciences (USNA) – Form 4 filed 07/28/2025. Director Timothy E. Wood reported transactions dated 07/24/2025 involving restricted stock units (RSUs) and common shares.

  • RSU exercise (Code M): 1,058 RSUs converted into an equal number of common shares at a stated price of $0.
  • Disposition for tax withholding (Code F): 265 shares sold at $32.09 per share.

After the transactions Wood now directly owns 8,235 common shares. He also retains 3,172 unvested RSUs that convert 25 % on 07/24/2025, 10/23/2025, 01/22/2026, and 04/23/2026.

The filing reflects a net increase of 793 shares in Wood’s direct equity position and provides updated ownership data but does not contain company-level financial results or forward-looking statements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.37%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
current report

FAQ

How many USANA HEALTH SCIENCES (USNA) SEC filings are available on StockTitan?

StockTitan tracks 124 SEC filings for USANA HEALTH SCIENCES (USNA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for USANA HEALTH SCIENCES (USNA)?

The most recent SEC filing for USANA HEALTH SCIENCES (USNA) was filed on July 28, 2025.